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ReassortmentMammalian orthoreoviruses (reoviruses) are highly useful models for studies of double-stranded RNA virus
replication and pathogenesis. We previously developed a strategy to recover prototype reovirus strain T3D
from cloned cDNAs transfected into murine L929 ﬁbroblast cells. Here, we report the development of a
second-generation reovirus reverse genetics system featuring several major improvements: (1) the capacity
to rescue prototype reovirus strain T1L, (2) reduction of required plasmids from 10 to 4, and (3) isolation of
recombinant viruses following transfection of baby hamster kidney cells engineered to express
bacteriophage T7 RNA polymerase. The efﬁciency of virus rescue using the 4-plasmid strategy was
substantially increased in comparison to the original 10-plasmid system. We observed full compatibility of
T1L and T3D rescue vectors when intermixed to produce a panel of T1L×T3D monoreassortant viruses.
Improvements to the reovirus reverse genetics system enhance its applicability for studies of reovirus
biology and clinical use.
© 2009 Elsevier Inc. All rights reserved.Introduction
One of the most transformative technologic advancements in
virology has been the development of reverse genetics systems for
nearly all major groups of RNA- and DNA-containing viruses.
Although the molecular design and methodologic details of these
systems vary, their common feature is the availability of cloned cDNAs
encoding viral genomes that can be manipulated and subsequently
used to isolate viruses containing engineered changes in genomic
nucleic acids. RNA virus rescue systems typically entail intracellular
transcription of full-length genomic or antigenomic RNAs from
plasmids transfected into permissive cells, frequently in conjunction
with transient expression of essential components of the viral
replicase (Bridgen and Elliott, 1996; Collins et al., 1995; Fodor et al.,
1999; Garcin et al., 1995; Lawson et al., 1995; Neumann et al., 1999;
Racaniello and Baltimore, 1981; Schneider et al., 2005; Schnell et al.,
1994; Whelan et al., 1995; Yoneda et al., 2006). Furthermore,
translational competence of (+)-strand RNA virus genomes hastric Research, D7235 MCN,
37232, USA. Fax: +1 615 343
Chappell),
t.
o University, Kyoto 606-8507,
ll rights reserved.enabled rescue of infectious virus from cells following introduction of
in vitro-generated genomic RNAs free of viral proteins (Almazan et al.,
2000; Coley et al., 2005; Gritsun and Gould, 1995; Kinney et al., 1997;
Racaniello and Baltimore, 1981; Rice et al., 1989; Yount et al., 2003;
Yun et al., 2003). Development of a fully plasmid-based reverse
genetics strategy for double-stranded (ds) RNA viruses of mammalian
species, which include coltiviruses, orbiviruses, reoviruses, and
rotaviruses, has trailed other major systems owing in part to the
technical complexities involved in manipulation of a multipartite
genome containing 10 or more segments. We have developed a
reverse genetics system for mammalian reovirus (Kobayashi et al.,
2007), a nonenveloped, double-layered particle containing 10 dsRNA
gene segments (Schiff et al., 2007), and used this system to engineer
changes in both structural and nonstructural proteins for studies of
reovirus replication and pathogenesis (Boehme et al., 2009; Danthi et
al., 2008a; Danthi et al., 2008b; Kirchner et al., 2008; Kobayashi et al.,
2007, 2009; Zurney et al., 2009).
The implications of targeted alterations of the reovirus genome are
highly signiﬁcant to current research focused on therapeutic use of
reovirus as an oncolytic agent (Kelly et al., 2009) and to conceptu-
alization of reovirus-vectored vaccines. Goals for our continuing work
with this technology include performance improvement in the form
of increased efﬁciency of virus recovery, broadened scope of
dissectible viral properties and phenotypes, expanded spectrum of
nonviral nucleic acids inserted into the viral genome, shortened time
to virus recovery, and reduced reagent preparation time and expense.
Fig. 1. Experimental strategy to generate reovirus type 1 Lang (T1L) from cloned cDNAs.
(A) Rescue plasmids containing T1L gene-segment cDNAs. Vectors contain cDNAs
representing each of the 10 full-length T1L gene segments. Reovirus cDNAs are ﬂanked
by the bacteriophage T7 RNA polymerase promoter (T7P) and the antigenomic
hepatitis delta virus (HDV) ribozyme (Rib). (B) Reverse genetics procedure. The 10 T1L
cDNA constructs are transfected into murine L cells that express T7 RNA polymerase
from recombinant vaccinia virus strain DIs-T7pol. Plasmid-derived transcripts
correspond to viral mRNAs with native 5′ termini. The 3′ termini of nascent transcripts
are fused to HDV ribozyme sequences, which generate authentic 3′ ends through
autocatalytic cleavage. After 5 days of incubation, transfected cells are lysed by freeze–
thaw, and recombinant strain (rs) viruses are isolated from lysates by plaque assay
using L cells.
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studies of reovirus biology and development of reovirus for clinical
applications.
The reovirus reverse genetics system is based on the serotype 3
prototype strain, type 3 Dearing (T3D; Kobayashi et al., 2007), and
consists of 10 plasmids, each containing a full-length reovirus gene-
segment cDNA under transcriptional control of the bacteriophage T7
RNA polymerase promoter and fused at the 3′ terminus with hepatitis
delta virus (HDV) ribozyme sequences. These plasmids are presumed
to generate transcripts identical in sequence to reovirus-generated
(+)-strand RNAs that serve as templates for translation and dsRNA
synthesis in infected cells. The primary round of reovirus replication is
initiated by co-transfection of all 10 plasmids into murine L929 (L)
cells infected with a replication-defective vaccinia virus expressing T7
RNA polymerase. Following 5 days of incubation, recombinant strain
(rs) viruses are isolated from co-transfection lysates by plaque assay
using L cells. The global replication behavior and strain-speciﬁc
phenotypes of rs viruses studied to date are qualitatively and
quantitatively consistent with the natural parental isolates (Danthi
et al., 2008a; Kobayashi et al., 2007, 2009). These results demonstrate
that the reovirus reverse genetics system is a biologically plausible
approach to study viral replication and pathogenesis, optimize viral
oncotropism, and develop reovirus as a live, naturally attenuated
vaccine vector for diverse pathogenic microorganisms.
Reovirus strain type 1 Lang (T1L) serves as the prototype for
serotype 1 reoviruses. Like T3D, T1L infection has been extensively
studied using cultured cells and in vivo. T1L and T3D display
numerous phenotypic differences including receptor usage, activities
of viral replication proteins, regulation of the interferon response to
reovirus infection, apoptosis induction, growth in various types of
primary and transformed cells, virulence, dissemination pathways,
and cell and tissue tropism in newborn mice (Schiff et al., 2007).
Reassortant viruses derived from co-infections of T1L and T3D have
been used to deﬁne the genetic basis of several of these biologic
polymorphisms. Such analyses have provided key insights into viral
replication and disease mechanisms. A marker rescue system for T1L
does not exist. However, the availability of tools to derive infectious
T1L particles starting with plasmid templates would greatly expand
the potential utility of reovirus reverse genetics by permitting any
desired combinatorial exchange of T1L and T3D gene segments and
providing an alternative genetic background to optimize cell targeting
and vectoring capacity.
A reduction in the total number of plasmids necessary to initiate
the reovirus replication cycle would improve certain practical aspects
of the reverse genetics system including effort and costs associated
with reagent preparation. A decreased plasmid requirement also
theoretically carries the possibility of increased co-transfection
efﬁciency resulting in enhanced virus isolation, which is particularly
relevant to recovery of viruses that replicate poorly. Introduction of
changes that handicap reovirus replicative ﬁtness is a productive
approach to the elucidation of structure–function relationships in
viral proteins (Kirchner et al., 2008; Kobayashi et al., 2006, 2009).
Therefore, technical enhancements such as construct consolidation
that potentially lower the efﬁciency barrier to virus replication should
strengthen system performance and broaden its utility.
In this report, we describe the establishment of reverse genetics
for strain T1L and validate performance of this system by isolation of
viable rsT1L and rsT3D single-gene reassortant viruses using plasmid
vectors. We improved the reovirus reverse genetics system by
consolidating viral gene-segment cDNAs into four plasmids. Com-
pared to the 10-plasmid system, this strategy permits more efﬁcient
virus recovery than the 10-plasmid system from L cells using
recombinant vaccinia virus as a source of T7 RNA polymerase. Finally,
we show that both T1L and T3D can be recovered following plasmid
transfection of baby hamster kidney (BHK) cells in which the T7 RNA
polymerase is constitutively expressed. These enhancements toreverse genetics for reovirus represent a signiﬁcant advance for this
technology.
Results
Plasmid-based reverse genetics for reovirus T1L
To generate T1L from cloned cDNAs, plasmids encoding each gene
segment were engineered in similar fashion to T3D cDNAs used for
reverse genetics (Kobayashi et al., 2007; Fig. 1). Each plasmid contains
one full-length gene-segment cDNA placed under control of the
bacteriophage T7 RNA polymerase promoter and appended with the
HDV ribozyme at the 3′terminus. These plasmids are anticipated to
generate full-length (+)-sense RNAs containing native 5′ and 3′ ends
following transcription with T7 RNA polymerase. L cells were infected
with replication-defective T7 RNA polymerase-expressing vaccinia
virus strain rDIs-T7pol 1 h prior to co-transfection with the 10 T1L
cDNA plasmids. Recombinant viruses were recovered from cell-
culture supernatants by plaque assay using L cell monolayers. Thus,
rsT1L can be recovered from plasmid-transfected cells.
Characterization of T1L obtained using reverse genetics
Genomic dsRNA segments of different reovirus strains produce
characteristic electrophoretic patterns when resolved using SDS–
PAGE (Barton et al., 2001). To conﬁrm that rsT1L contains the correct
combination of gene segments, genomic dsRNA isolated from native
T1L and rsT1L virions was electrophoresed in an SDS–polyacrylamide
gel and visualized by ethidium bromide staining (Fig. 2A). The
electropherotype of rsT1L was indistinguishable from that of
native strain T1L. To exclude the possibility that rsT1L represents
Fig. 2. Characterization of T1L viruses derived using reverse genetics. (A) Electro-
pherotypes of native T1L and plasmid-derived rsT1L. Puriﬁed virions were electro-
phoresed in an SDS–polyacrylamide gel, followed by ethidium bromide staining to
visualize viral gene segments. Size classes of gene segments (L, M, S) are indicated.
(B)Novelmutations in the L3 gene of rs viruses. The C→T change at nucleotide 2059 and
G→C change at nucleotide 2062 eliminate a unique PmlI site. (C) Digestion of the L3
gene RT-PCR products of T1L and rsT1Lwith PmlI to conﬁrm the presence or absence of a
unique restriction site. Size markers are indicated. (D) Growth of T1L and rsT1L. L cells
were adsorbed with T1L or rsT1L at an MOI of 2 PFU/cell, and viral titers in cell lysates
were determined by plaque assay at the times shown. Results are presented as mean
viral titers for triplicate experiments. Error bars indicate S.D. (E) Immunoﬂuorescence
analysis of cells infected with T1L and rsT1L. L cells were adsorbed with either T1L or
rsT1L and stained at 24 h post-infection with μNS-speciﬁc antiserum followed by a
ﬂuorophore-conjugated, goat-anti-rabbit secondary antibody to visualize reovirus
inclusions. Representative images of T1L- and rsT1L-infected cells are shown.
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destroyed by the introduction of two silent point mutations into the
L3 rescue plasmid: C to T at nucleotide 2059 and G to C at nucleotide
2062 (Fig. 2B). A 1189-bp fragment of the L3 genewas ampliﬁed using
RT-PCR of viral dsRNA extracted from T1L and rsT1L virions. The L3
gene RT-PCR product derived from T1L was digested with PmlI to
produce 586- and 603-bp fragments, whereas the L3 product derived
from rsT1L was not (Fig. 2C), indicating that rsT1L originated from
plasmids. To ascertain whether rsT1L and native T1L have similar
replication kinetics, yields of rsT1L and T1L were quantiﬁed following
infection of L cells at an MOI of 2 PFU/cell (Fig. 2D). Titers of rsT1L and
T1L were virtually identical at all time points tested.Reoviruses form characteristic cytoplasmic inclusions in infected
cells (Becker et al., 2003; Kobayashi et al., 2009; Miller et al., 2004).
These inclusions are thought to represent sites of viral genome
replication and vary in morphology dependent on the infecting strain.
T1L forms ﬁlamentous inclusions, whereas the inclusions formed by
T3D are globular (Parker et al., 2002). To determine whether rsT1L
inclusions are similar to those produced by T1L, L cells were infected
with each virus, ﬁxed at 24 h post-infection, and imaged using
confocal microscopy (Fig. 2E). Inclusions formed by rsT1L and T1L
were indistinguishable and displayed ﬁlamentous morphology. Taken
together, these data demonstrate comparable replication character-
istics of rsT1L and native T1L.
Generation of an improved reverse genetics system using four
plasmid vectors
To reduce the number of plasmids required for reverse genetics,
two or four T1L gene transcription cassettes encoding reovirus cDNAs
ﬂanked by the T7 RNA polymerase promoter and HDV ribozyme were
combined in a single plasmid (Fig. 3A). Speciﬁcally, L1 and M2 (pT7-
L1-M2T1L), L2 and M3 (pT7-L2-M3T1L), L3 and S3 (pT7-L3-S3T1L),
and S1, S2, S4, and M1 (pT7-M1-S1-S2-S4T1L) transcription cassettes
were jointly introduced into the rescue backbone plasmid using PCR
to generate requisite restriction enzyme recognition sites compatible
with multiplex cloning (Fig. 3A).
To assess rescue efﬁciency of the 4-plasmid system, L cells were
infected with vaccinia virus strain rDIs-T7pol 1 h prior to transfection
with the 4- or 10-plasmid vector set, and viral titers in transfected cell
lysates were determined at 24 and 48 h post-transfection by plaque
assay using L cell monolayers. Viral titers following transfection with
10 plasmids encoding the T1L genomewere 10 and 1000 PFU/ml at 24
and 48 h, respectively. However, viral titers following transfection
with the 4-plasmid T1L cDNA vector set weremarkedly higher at both
24 h (1000 PFU/ml) and 48 h (10,000 PFU/ml) post-transfection
(Fig. 3B). Thus, transfection with four plasmids substantially enhances
rescue efﬁciency.
A 4-plasmid reverse genetics system was also developed for T3D.
Using this strategy, L1 and S1 (pT7-L1-S1T3D), L2 and M3 (pT7-L2-
M3T3D), L3 and M1 (pT7-L3-M1T3D), and M2, S2, S3, and S4 (pT7-
M2-S2-S3-S4T3D) gene cassettes were introduced into individual
plasmids (Fig. 3C). To compare the efﬁciency of the T3D rescue
systems, the T3D 4-plasmid and 10-plasmid vector sets were
independently transfected into rDIs-T7pol-infected L cells, and viral
titers in culture lysates were determined by plaque assay at 24 and 48
h. Viral titers in cultures transfected with 10 plasmids were below the
limit of detection at 24 h and ∼100 PFU/ml at 48 h. In contrast, L cell
cultures transfected with four plasmids produced ∼100 PFU/ml of
virus at 24 h and ∼1000 PFU/ml at 48 h (Fig. 3D). From these data, we
conclude that both T1L and T3D can be recovered using four plasmids
and that a reduction in plasmid number substantially improves rescue
efﬁciency.
Generation of rsT1L×rsT3D monoreassortant viruses
Using a combination of the 4-plasmid and 10-plasmid rescue
systems, we generated a panel of 20 rsT1L×rsT3D monoreassortant
viruses. These viruses contain nine genes from one parental strain and
one gene from the other. Genotypes of recovered viruses were
conﬁrmed using a combination of gene-segment electrophoretic
mobility and sequence analysis (data not shown). The electrophoretic
pattern of a representative monoreassortant, rsT1L-T3M1, which
contains the T3D M1 gene segment in an otherwise T1L background,
clearly shows co-migration of the M1 RNA with that of T3D (Fig. 4).
Conversely, the M1 RNA of the reciprocal reassortant virus, rsT3D-
T1M1, co-migrates with T1L M1. The generation of T1L×T3D
monoreassortant viruses demonstrates the versatility of the reverse
Fig. 3. Improved reverse genetics for reovirus strains T1L and T3D. (A, C) Two or four gene transcription cassettes encoding reovirus cDNAs ﬂanked by the T7 RNA polymerase
promoter and HDV ribozyme sequences were combined into single plasmids, creating four plasmids for the T1L and T3D reverse genetics systems. (B, D) L cells expressing T7
polymerase were co-transfected with either 4 or 10 rescue plasmids corresponding to the T1L (A,B) and T3D (C,D) genomes. Following 24 or 48 h incubation, transfected cells were
lysed by freeze–thaw, and viral titers in cell lysates were determined by plaque assay. Results are presented as mean viral titers for triplicate experiments. Error bars indicate S.D.
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combination, including monoreassortants, which have traditionally
been the most difﬁcult to obtain by co-infection of cells with T1L and
T3D.
Generation of rs viruses using BHK-T7 cells
BHK cells have been engineered to stably express T7 RNA
polymerase (BHK-T7) under control of a cytomegalovirus promoter
(Buchholz et al., 1999). To determine whether these cells allow
recovery of viable reovirus following plasmid transfection, thus
eliminating the requirement for rDIs-T7pol, we transfected BHK-T7
cells with the T1L or T3D 4-plasmid vector sets in the absence of rDIS-
T7pol and determined viral titers in transfected cell lysates by plaque
assay at 48 h post-transfection (Fig. 5). We found that transfection
with either T1L or T3D cDNAs led to substantial viral titers at 48
h post-transfection. From these results, we conclude that BHK-T7 cells
can be used as an alternative to rDIs-T7pol-infected L cells for the
recovery of reovirus using plasmid vectors.
Discussion
The prototype strain for type 1 reovirus, T1L, has been studied
extensively in replication and pathogenesis models. Therefore, a
primary goal of this studywas to generate a reverse genetics system for
T1L. As demonstrated for strain T3D (Boehme et al., 2009; Danthi et al.,
2008a, 2008b; Kirchner et al., 2008; Kobayashi et al., 2007, 2009;
Zurney et al., 2009), development of a reverse genetics system for T1L
affords an opportunity to leverage an extensive knowledge base of
virus structure and biology toward further acceleration of basic and
applied reovirus research. Here, we show production of T1L virions
from cloned cDNAs. Similar to rsT3D and native T3D, the replication
characteristics of rsT1L reﬂect native T1L. Growth kinetics, total yields,
inclusion morphology, and genomic electrophoretic signatures were
indistinguishable between T1L and rsT1L. These results further
validate retention of native viral properties by plasmid-derivedviruses. Moreover, development of the T1L rescue system will expand
the utility of reverse genetics for studies of reovirus biology.
Analysis of a large panel of T1L×T3D reassortant viruses has
shown that reovirus gene segments display nonrandom segregation
upon co-infection of L cells by the parental strains (Nibert et al.,
1996). This observation suggests that there may be interactions
among viral proteins, RNAs, or both that inﬂuence reovirus evolution.
Additionally, compensatory mutations that promote viral replication
efﬁciency may be necessary to stabilize certain genetic combinations
(Roner et al., 1995). Prior to this study, it was unclear whether
generation of all 20 single-gene T1L×T3D reassortant viruses would
be feasible due to uncertainties about the replicative ﬁtness of gene
constellations not previously isolated in T1L×T3D reassortant panels.
Development of a fully plasmid-based rescue system for T1L will
now allow systematic characterization of gene-segment co-evolution
and may facilitate isolation of viruses with replication impediments
or combinations of T1L and T3D genes normally disfavored in mixed
infections (Nibert et al., 1996).
Establishment of reverse genetics for reovirus has allowed
engineering of mutations into structural and nonstructural reovirus
proteins and provided an opportunity to observe the effects of these
mutations on viral replication and pathogenesis in the context of
infection. However, the current system is limited by the inefﬁciency of
transfection of 10 plasmids (Kobayashi et al., 2007). Therefore, a
second goal of this study was to improve viral yields by reducing the
number of plasmids required for virus recovery. This goal was
accomplished by combining two or four transcriptional cassettes in a
single plasmid, reducing the total number of plasmids from 10 to 4.
Compared to theﬁrst-generationmarker rescue system, the 4-plasmid
strategy enhanced efﬁciency of virus recovery by reducing time to
virus isolation and supporting increased total yields. The improved
reverse genetics system also offers the economic advantage of
requiring fewer reagents and less preparation time. Interestingly,
recovery of T1L appears to be more efﬁcient than T3D using either the
4- or 10-plasmid reverse genetics system. While the simplest
explanation is that T1L exhibits an intrinsic replication advantage
Fig. 5. Recombinant virus generated using BHK-T7 cells. (A) Schematic of reovirus
reverse genetics system using BHK-T7 cells. (B) BHK-T7 cells were co-transfected
with four rescue plasmids corresponding to the T1L and T3D genomes. Following
48-h incubation, transfected cells were lysed by freeze–thaw, and viral titers in cell
lysates were determined by plaque assay.
Fig. 4. Representative electropherotype of recombinant monoreassortant viruses.
Puriﬁed virions of rsT1L, rsT3D, and T1L×T3D monoreassortants containing reciprocal
exchanges of the M1 gene, rsT1L-T3M1 and rsT3D-T1M1, were electrophoresed in an
SDS–polyacrylamide gel, followed by ethidium bromide staining to visualize viral gene
segments. Size classes of gene segments (L, M, S) are shown. Positions of the T1L and
T3D M1 genes are indicated by round and diamond symbols, respectively.
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different gene arrangements between the T1L and T3D 4-plasmid
systems contribute to higher yields of T1L. Whether genetic linkage
within the rescue constructs affects virus production is unknown.
The 4-plasmid reverse genetics system reported here could
conceivably enhance efﬁciency of virus recovery by three nonmu-
tually exclusive mechanisms. First, since fewer plasmids are required
to simultaneously enter a cell, the probability is increased that a full
set of viral RNAs will accumulate to a critical threshold for replication
initiation. While plasmids are provided in vast excess, there may be a
limit to the amount of plasmid that can enter a single cell. Second, it is
possible that only a small fraction of transfected plasmids avoid
degradation and remain competent for transcription. By decreasing
the number of plasmids from 10 to 4, the likelihood that a single cell
will contain a sufﬁcient number of intact transcription cassettes is
enhanced. Third, it is possible that constraining transcription and
translation of individual viral RNAs to the same intracellular
microenvironment, as might be anticipated for multicistronic vectors,
facilitates essential protein–protein or protein–RNA interactions
required for virus recovery.
Technical complexities associated with manipulation of multi-
cistronic vectors may limit their use for certain applications.
Therefore, the 10-plasmid system remains a useful alterative for
demanding cloning tasks. Tetracistronic vectors can be reduced to
tricistronic constructs by simple endonucleolytic excision of a gene-
segment cDNA and then complemented by co-transfection with the
corresponding single-gene vector containing the desired mutations.We have found that the 4- and 10-plasmid vector systems are fully
compatible for virus rescue. Hence, the monocistronic vectors remain
important adjuncts to the 4-plasmid strategy by combining enhanced
ﬂexibility with gains in efﬁciency.
In our effort to improve reovirus reverse genetics, we found that
BHK-T7 cells, which constitutively express T7 RNA polymerase
(Buchholz et al., 1999), allow recovery of both rsT1L and rsT3D. The
capacity of BHK-T7 cells to support virus rescue obviates the
requirement for rDIs-T7pol and thereby greatly simpliﬁes the rescue
protocol. BHK-T7 cells are easier to maintain and propagate than rDIs-
T7pol and thus provide an additional improvement to the reovirus
rescue system.
Our progress with reovirus reverse genetics in many respects
parallels the evolution of reverse genetics technology for inﬂuenza
virus, which has also been modiﬁed to improve efﬁciency. Early
reverse genetics systems for inﬂuenza virus required co-transfection
of 12–16 plasmids encoding viral mRNAs or proteins (Neumann et al.,
1999). Subsequently, the number of required plasmids was reduced
to 8; each containing a viral gene ﬂanked by both pol I and pol II
promoters that drive viral genomic and messenger RNA expression,
from the same cDNA (Hoffmann et al., 2000). As these systems were
practical only in cell types supporting high transfection efﬁciencies,
further improvements were achieved by combining eight RNA pol I
transcription cassettes for viral RNA synthesis into a single plasmid
and condensing three of the four protein expression cassettes onto
one plasmid. The resulting 3-plasmid system increases efﬁciency of
virus production in Vero cells, which are amenable to propagation of
inﬂuenza vaccines for use in humans (Neumann et al., 2005). Hence,
reverse genetics of viruses containing segmented genomes appears to
be inherently inefﬁcient, but this problem is surmountable through
plasmid reduction.
We have established an improved reverse genetics system of
reovirus that allows recovery of prototype strain T1L from plasmid
vectors and reduces the number of plasmids for both the T1L and T3D
systems. These enhancements have increased the ﬂexibility and
efﬁciency of reverse genetics for basic studies of reovirus biology and
will accelerate development of reovirus for clinical and technological
purposes.
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Cells and viruses
L cells were grown in Joklik's modiﬁed Eagle's minimal essential
medium (Irvine Scientiﬁc) supplemented to contain 5% fetal calf
serum (Gibco), 2 mM L-glutamine, 100 U of penicillin G/ml, 100 μg of
streptomycin/ml, and 0.25 μg amphotericin B/ml (Gibco). BHK-T7
cells were grown in Dulbecco's modiﬁed Eagle's minimal essential
medium (Invitrogen) supplemented to contain 5% fetal calf serum, 2
mM L-glutamine, 2% MEM amino acid solution (Invitrogen), and 1
mg/ml geneticin (Invitrogen). Reovirus strains T1L and T3D are
laboratory stocks originally obtained from the laboratory of Dr.
Bernard Fields. Strain rsT3D was produced by reverse genetics
(Kobayashi et al., 2007). Virus was puriﬁed from L cells by CsCl-
gradient centrifugation (Furlong et al., 1988). Viral titers were
determined by plaque assay using L cell monolayers as described
(Virgin et al., 1988). Attenuated vaccinia virus strain rDIs-T7pol
expressing T7 RNA polymerase (Ishii et al., 2002) was propagated in
chicken embryo ﬁbroblasts.
Plasmid construction
T1L plasmid cDNAs for rescue of recombinant infectious reovirus
were constructed using RT-PCR, viral genomic RNA, and gene-speciﬁc
primer sets (Table 1). RT-PCR products were cloned into the SmaI–
RsrII (L1, L2, and S3), SmaI–BseRI (S2), EcoRV–RsrII (M3), or EcoRV–
BseRI (S4) sites of p3E5EGFP (Watanabe et al., 2004), resulting in pT7-
L1T1L, pT7-L2T1L, pT7-M3T1L, pT7-S2T1L, pT7-S3T1L, and pT7-S4T1L.
The T1L L3 gene cDNA, ampliﬁed from viral genomic RNAwith speciﬁc
primers (Table 1), was inserted into the EcoRI–RsrII site of pT7-L3T3D
(Kobayashi et al., 2007), thereby replacing the T3D L3 cDNA and
generating pT7-L3T1L. pT7-M2T1L was constructed by insertion into
the p3E5EGFP RsrII site of RT-PCR ampliﬁcation products generated
with viral genomic RNA and speciﬁc primers (Table 1). The resulting
construct containing the cloned T1L M2 gene was digested with SmaI
and AvrII, followed by self-ligation to remove GFP-encoding
sequences and the Ebola virus leader and trailer sequences. pT7-
M1T1L and pBacT7-S1T1L, encoding T1L M1 and S1 genes, respec-
tively, were described previously (Kobayashi et al., 2007, 2009).
Recombinant reovirus generation from four plasmids was facili-
tated by combining two or four viral gene transcription cassettes
encoding T1L and T3D reovirus cDNAs ﬂanked by the T7 RNA
polymerase promoter (5′) and HDV ribozyme (3′) onto one plasmid.
Bicistronic reovirus cDNA constructs pT7-L1-M2T1L (T1L L1 and M2),
pT7-L2-M3T1L (T1L L2 and M3), pT7-L3-S3T1L (T1L L3 and S3), pT7-
L1-S1T3D (T3D L1 and S1), pT7-L2-M3T3D (T3D L2 andM3), and pT7-Table 1
Oligodeoxynucleotide primers used for plasmid construction.
Plasmid DNA Nucleotide sequencea
pT7-L1T1L Forward 5'-TAACCC
Reverse 5'-GGTCG
pT7-L2T1L Forward 5'-TAACCC
Reverse 5'-GGTCG
pT7-L3T1L Forward 5'-TAAGA
Reverse 5'-GGTCG
pT7-M2T1L Forward 5'-CCTCGC
Reverse 5'-GGTCG
pT7-M3T1L Forward 5'-TAAGA
Reverse 5'-GGTCG
pT7-S2T1L Forward 5'-TAACCC
Reverse 5'-ACCGC
pT7-S3T1L Forward 5'-TAACCC
Reverse 5'-GGTCG
pT7-S4T1L Forward 5'-TAAGA
Reverse 5'-CGCGA
a The T7 RNA polymerase promoter sequence is underlined.L3-M1 (T3D L3 and M1) were generated by cloning PCR-ampliﬁed
T1L M2, T1L M3, T1L S3, T3D S1, T3D M3, and T3D M1 gene
transcription cassettes into the SphI site of pT7-L1T1L, NheI site of
pT7-L2T1L, HindIII site of pT7-L3T1L, HindIII site of pT7-L1T3D, NheI
site of pT7-L2T3D, and HindIII site of pT7-L3T3D, respectively.
Tetracistronic reovirus cDNA constructs, pT7-M1-S1-S2-S4T1L (T1L
S1, S2, S4, and M1) and pT7-M2-S2-S3-S4T3D (T3D S2, S3, S4, and
M2), were generated by cloning PCR-ampliﬁed T1L S3, T1L S4, T1L
M1, T3D S3, T3D S4, and T3D M2 gene transcription cassettes into
the XbaI (T1L S1), SalI (T1L S4), or NheI (T1L M1) sites of pT7-S2T1L
or SalI–HindIII (T3D S3), HindIII–NheI (T3D S4), or NheI (T3D M2)
sites of pT7-S2T3D.
Plasmid transfection and recovery of recombinant virus using L cells
Monolayers of L cells at 90% conﬂuency (approximately 3×106
cells) seeded in 60-mm dishes (Costar) were infected with rDIs-T7pol
at an MOI of approximately 0.5 TCID50. At 1 h post-infection, cells
were co-transfected with plasmids representing the cloned reovirus
genome using 3 μl of TransIT-LT1 transfection reagent (Mirus) per
microgram of plasmid DNA. The amount of each plasmid used for
transfection was given as follows: pT7-L1T1L, 2 μg; pT7-L2T1L, 2 μg;
pT7-L3T1L, 2 μg; pT7-M1T1L, 1.75 μg; pT7-M2T1L, 1.75 μg; pT7-
M3T1L, 1.75 μg; pBacT7-S1T1L, 2 μg; pT7-S2T1L, 1.5 μg; pT7-S3T1L, 1.5
μg; pT7-S4T1L, 1.5 μg; pT7-L1-M2T1L, 4.5 μg; pT7-L2-M3T1L, 4.5 μg;
pT7-L3-M3T1L, 4.5 μg; pT7-M1-S1-S2-S4T1L, 4.5 μg; pT7-L1-S1T3D,
4.5 μg; pT7-L2-M3T3D, 4.5 μg; pT7-L3-M1T3D, 4.5 μg; and pT7-M2-
S2-S3-S4T3D, 4.5 μg. Quantities of T3D monocistronic plasmid were
used as previously described (Kobayashi et al., 2007). Following 1–5
days of incubation, recombinant virus was isolated from transfected
cells by plaque puriﬁcation using L cells (Virgin et al., 1988).
SDS–PAGE analysis of viral gene segments
Puriﬁed virions (5×1010 particles) were loaded into wells of 10%
SDS–polyacrylamide gels. Gels were electrophoresed for approxi-
mately 600 m Amp-h. Gene segments were visualized by ethidium
bromide staining.
Quantiﬁcation of virus infectivity
Monolayers of L cells (5×105 cells) seeded in 24-well plates
(Costar) were adsorbed with virus at an MOI of 2 PFU/cell. After 1
h adsorption at room temperature, the inoculum was removed, cells
were washed with PBS, and fresh medium was added. Cells were
incubated at 37 °C for various intervals, and viral titers in cell lysates
were determined by plaque assay using L cells (Virgin et al., 1988).GGGTAATACGACTCACTATAGCTACACGTTCCACGACAATGTCATCCA-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAGTTGACGCACCACGACCCAT-3'
GGGTAATACGACTCACTATAGCTATTGGCGCAATGGCGAACGTTTGGG-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAATTAGGCACGCTCACGAGGG-3'
ATTCTAATACGACTCACTATAGCTAATCGTCAGGATGAAGCGGATTCCA-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAATCGGCCCAACTAGCATCGA-3'
GGTCCGACCTGGGGTTAATACGACTCACTATAGCTAATCTGCTGACCGTCACTCT-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGATGTGCCTGCACCCTTAACC-3'
TATCTAATACGACTCACTATAGCTAAAGTGACCGTGGTCATGGCTTCAT-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGAATAGGGGTCGGGAAGGCTTA-3'
GGGTAATACGACTCACTATAGCTATTCGCTGGTCAGTTATGGCT-3'
GAGGAGGTGGAGATGCCATGCCGACCCGATGAATGTGTGGTCAGTCGTGAGGGGTGTG-3'
GGGTAATACGACTCACTATAGCTAAAGTCACGCCTGTTGTCGTCAC-3'
GACCGCGAGGAGGTGGAGATGCCATGCCGACCCGATGATTAGGCGCCACCCACCACC-3'
TATCTAATACGACTCACTATAGCTATTTTTGCCTCTTCCCAAACG-3'
GGAGGTGGAGATGCCATGCCGACCCGATGAATGGAGCCTGTCCCACGTC-3'
200 T. Kobayashi et al. / Virology 398 (2010) 194–200Immunoﬂuorescence detection of reovirus infection
L cells were plated on glass coverslips in 24-well plates (Costar)
and adsorbed at an MOI of 2 PFU/cell. Following incubation at 37 °C
for 24 h, cells were ﬁxed and stained with rabbit μNS antiserum
followed by ﬂuorophore-conjugated, goat anti-rabbit secondary
antibody (Invitrogen). Images were acquired using a Zeiss LSM 510
META inverted confocal system (Carl Zeiss) with a Zeiss inverted
Axiovert 200M microscope.
Plasmid transfection and recovery of recombinant virus using BHK-T7
cells
Monolayers of BHK-T7 cells at 90% conﬂuency (approximately
3×106 cells) seeded in 60-mm dishes were co-transfected with
plasmids representing the cloned reovirus genome using 3 μl of
TransIT-LT1 transfection reagent (Mirus) per microgram of plasmid
DNA. The amount of each plasmid used for transfection was identical
to that described for L cell transfection. Following 1–5 days of
incubation, recombinant virus was isolated from transfected cells by
plaque puriﬁcation using monolayers of L cells (Virgin et al., 1988).
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